BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 332158)

  • 21. Mutagenicity of aflatoxin B1, activated by S-9 fractions of human, rat, mouse, rabbit, and monkey liver, towards S. typhimurium TA 98.
    Norpoth K; Grossmeier R; Bösenberg H; Themann H; Fleischer M
    Int Arch Occup Environ Health; 1979 Jan; 42(3-4):333-9. PubMed ID: 106015
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative mutagenicity of aflatoxins using a Salmonella/trout hepatic enzyme activation system.
    Coulombe RA; Shelton DW; Sinnhuber RO; Nixon JE
    Carcinogenesis; 1982; 3(11):1261-4. PubMed ID: 6758974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aflatoxin B1 mutagenesis, DNA binding, and adduct formation in Salmonella typhimurium.
    Stark AA; Essigmann JM; Demain AL; Skopek TR; Wogan GN
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1343-7. PubMed ID: 375236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The enhancement of the effect of aflatoxin B1 by metabolic activation with rat-liver microsomes on human lymphocytes assayed with the micronucleus test.
    Iskandar O; Vijayalaxmi
    Mutat Res; 1981 Jan; 91(1):63-6. PubMed ID: 7207495
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparative study of monooxygenase activity in elasmobranchs and mammals: activation of the model pro-carcinogen aflatoxin B1 by liver preparations of calf, nurse shark and clearnose skate.
    Bodine AB; Luer CA; Gangjee S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(2):255-7. PubMed ID: 2866897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promutagen activation in parasite-infected organisms: preliminary observations with Fasciola hepatica-infected mice and aflatoxin B1.
    Gentile JM; DeRuiter E
    Toxicol Lett; 1981; 8(4-5):273-82. PubMed ID: 6791314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of aflatoxin B1 by using the synergistic effect of hydrogen peroxide and gamma radiation.
    Patel UD; Govindarajan P; Dave PJ
    Appl Environ Microbiol; 1989 Feb; 55(2):465-7. PubMed ID: 2497710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of mutations in DNA-repair deficient bacteria by a liver microsomal metabolite of aflatoxin B1.
    Garner RC; Wright CM
    Br J Cancer; 1973 Dec; 28(6):544-51. PubMed ID: 4593223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifying role of dietary factors on the mutagenicity of aflatoxin B1: in vitro effect of vitamins.
    Bhattacharya RK; Francis AR; Shetty TK
    Mutat Res; 1987 Jun; 188(2):121-8. PubMed ID: 3108659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of mutagenicity to Salmonella typhimurium of some Fusarium mycotoxins.
    Wehner FC; Marasas WF; Thiel PG
    Appl Environ Microbiol; 1978 Apr; 35(4):659-62. PubMed ID: 348106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of substrates and inhibitors of monoamine oxidase on hepatic dimethylnitrosamine metabolism and mutagenicity.
    Lake BG; Rowland IR; Harris RA; Collins MA; Phillips JC; Cottrell RC; Gangolli SD
    Adv Exp Med Biol; 1981; 136 Pt B():1143-7. PubMed ID: 6283820
    [No Abstract]   [Full Text] [Related]  

  • 32. Formation of a factor lethal for S. typhimurium TA1530 and TA1531 on incubation of aflatoxin B 1 with rat liver microsomes.
    Garner RC; Miller EC; Miller JA; Garner JV; Hanson RS
    Biochem Biophys Res Commun; 1971 Nov; 45(3):774-80. PubMed ID: 4399636
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-aflatoxin mutagenic factors in corn.
    Weng CY; Martinez AJ; Park DL
    Food Addit Contam; 1997 Apr; 14(3):269-79. PubMed ID: 9135724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation and mutation induction in bacteria by microsomal metabolites.
    Garner RC
    Biochem Soc Trans; 1975; 3(1):65-9. PubMed ID: 1092573
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutagenicity of five cyclic N-nitrosamines: assay with Salmonella typhimurium.
    Stoltz DR; Sen NP
    J Natl Cancer Inst; 1977 Feb; 58(2):393-4. PubMed ID: 319245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fate of epoxides.
    Oesch F
    Adv Exp Med Biol; 1981; 136 Pt A():39-52. PubMed ID: 7046377
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition by specific antibodies of the mutagenicity of aflatoxin B1 in bacteria.
    Sizaret P; Malaveille C; Brun G; Aguelon AM; Toussaint G
    Oncodev Biol Med; 1982; 3(2-3):125-34. PubMed ID: 6812028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The biochemical activity of the aflatoxins (author's transl)].
    Reiss J
    Zentralbl Bakteriol B; 1978 Dec; 167(5-6):435-42. PubMed ID: 373323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rationale for the non-mutagenicity of 2- and 3-aminobiphenyls.
    Ioannides C; Lewis DF; Trinick J; Neville S; Sertkaya NN; Kajbaf M; Gorrod JW
    Carcinogenesis; 1989 Aug; 10(8):1403-7. PubMed ID: 2665965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.
    Forrester LM; Neal GE; Judah DJ; Glancey MJ; Wolf CR
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8306-10. PubMed ID: 2122459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.